Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

21.68 +0.16 (+0.74%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

NASDAQ:FLGT Investor Notice: Lawsuit Alleges Securities Laws Violations by Fulgent Genetics, Inc. ↗

October 05, 2022

San Diego, CA -- (SBWIRE) -- 10/05/2022 -- An investor, who purchased shares of Fulgent Genetics, Inc. (NASDAQ:FLGT), filed a lawsuit over alleged violations of Federal Securities Laws by Fulgent...

Via SBWire

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT

October 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

A Look Into Healthcare Sector Value Stocks ↗

October 03, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm

October 02, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT

October 02, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Fulgent Genetics, Inc. Class Action Lawsuit: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against Fulgent Genetics, Inc. (FLGT)

September 29, 2022

From Robbins LLP

Via Business Wire

Investor Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Announces Class Action and Encourages Shareholders to Contact the Firm and Actively Participate

September 29, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

September 27, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

FLGT INVESTOR NOTICE: ROSEN, A LEADING AND RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FLGT

September 26, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

September 26, 2022

From Law Offices of Howard G. Smith

Via Business Wire

INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit Filed against Fulgent Genetics, Inc.

September 24, 2022

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

FULGENT GENETICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT

September 22, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

September 22, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR NOTICE: Investors in Fulgent Genetics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – FLGT

September 22, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Fulgent Genetics, Inc. Investor Alert: Robbins LLP Informs Shareholders of Class Action Against Fulgent Genetics, Inc. (FLGT)

September 21, 2022

From Robbins LLP

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

September 21, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Fulgent Genetics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

September 21, 2022

From Rosen Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fulgent Genetics, Inc. (FLGT) Investors

September 21, 2022

From Law Offices of Howard G. Smith

Via Business Wire

INVESTOR ALERT: Fulgent Genetics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Fulgent Genetics Class Action Lawsuit - FLGT

September 21, 2022

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

September 21, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

September 20, 2022

From The Schall Law Firm

Via Business Wire

Fulgent Genetics's Return On Invested Capital Insights ↗

August 22, 2022

Pulled from Benzinga Pro data, Fulgent Genetics (NASDAQ:FLGT) posted Q2 earnings of $11.10 million, an increase from Q1 of 92.77%. Sales dropped to $125.34 million, a 60.86% decrease between quarters.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Fulgent Genetics, Inc. (FLGT)

August 10, 2022

From Kirby McInerney LLP

Via Business Wire

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

August 08, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 08, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

August 08, 2022

From The Schall Law Firm

Via Business Wire

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm

August 07, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm

August 05, 2022

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors

August 05, 2022

From Law Offices of Howard G. Smith

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.